Danny Chou is an Assistant Professor of Pediatrics (Endocrinology and Diabetes) at Stanford University. He received his Ph.D. from Harvard University, working in the lab of Prof. Stuart Schreiber in 2011. His Ph.D. research involved the identification of suppressors of cytokine-induced apoptosis in pancreatic beta cells. He then moved to MIT, where he was a JDRF Postdoctoral Fellow in the Department of Chemical Engineering. He worked under the guidance of Profs. Robert Langer and Daniel Anderson, focusing on the development of glucose-responsive insulin derivatives.

Marijuana use and heart-attack risk were correlated in a large human study, Stanford scientists and their collaborators found. A molecule in soybeans may counteract these effects.

In a trial of the two low-carb diets, both were similarly effective in controlling blood glucose. Keto’s more severe carb restrictions did not provide additional overall health benefits.

In addition to diabetes research, the work has already been used to study infectious diseases rooted in blood vessels

Carolyn Bertozzi, who founded the field of bioorthogonal chemistry, a class of chemical reactions compatible with living systems, has been awarded the 2022 Dickson Prize in Medicine, the University of Pittsburgh School of Medicine’s highest honor.